These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 34681213)

  • 1. Synthesis, Characterization and In Vitro Evaluation of Hybrid Monomeric Peptides Suited for Multimodal Imaging by PET/OI: Extending the Concept of Charge-Cell Binding Correlation.
    Maspero M; Cheng X; von Kiedrowski V; Dallanoce C; Wängler B; Hübner R; Wängler C
    Pharmaceuticals (Basel); 2021 Sep; 14(10):. PubMed ID: 34681213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PESIN Conjugates for Multimodal Imaging: Can Multimerization Compensate Charge Influences on Cell Binding Properties? A Case Study.
    Hübner R; Paretzki A; von Kiedrowski V; Maspero M; Cheng X; Davarci G; Braun D; Damerow H; Judmann B; Filippou V; Dallanoce C; Schirrmacher R; Wängler B; Wängler C
    Pharmaceuticals (Basel); 2021 Jun; 14(6):. PubMed ID: 34199635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional Hybrid Molecules for the Visualization of Cancer: PESIN-Homodimers Combined with Multimodal Molecular Imaging Probes for Positron Emission Tomography and Optical Imaging: Suited for Tracking of GRPR-Positive Malignant Tissue*.
    Hübner R; Cheng X; Wängler B; Wängler C
    Chemistry; 2020 Dec; 26(69):16349-16356. PubMed ID: 32618007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hybrid Multimodal Imaging Synthons for Chemoselective and Efficient Biomolecule Modification with Chelator and Near-Infrared Fluorescent Cyanine Dye.
    Hübner R; von Kiedrowski V; Benkert V; Wängler B; Schirrmacher R; Krämer R; Wängler C
    Pharmaceuticals (Basel); 2020 Sep; 13(9):. PubMed ID: 32948032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal modifications improve the receptor affinity and pharmacokinetics of radiolabeled peptidic gastrin-releasing peptide receptor antagonists: examples of 68Ga- and 64Cu-labeled peptides for PET imaging.
    Gourni E; Mansi R; Jamous M; Waser B; Smerling C; Burian A; Buchegger F; Reubi JC; Maecke HR
    J Nucl Med; 2014 Oct; 55(10):1719-25. PubMed ID: 25146125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (18)F, (64)Cu, and (68)Ga labeled RGD-bombesin heterodimeric peptides for PET imaging of breast cancer.
    Liu Z; Yan Y; Liu S; Wang F; Chen X
    Bioconjug Chem; 2009 May; 20(5):1016-25. PubMed ID: 20540537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-Modality Imaging of Prostate Cancer with a Fluorescent and Radiogallium-Labeled Gastrin-Releasing Peptide Receptor Antagonist.
    Zhang H; Desai P; Koike Y; Houghton J; Carlin S; Tandon N; Touijer K; Weber WA
    J Nucl Med; 2017 Jan; 58(1):29-35. PubMed ID: 27516447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative PET imaging study of
    Ferguson S; Wuest M; Richter S; Bergman C; Dufour J; Krys D; Simone J; Jans HS; Riauka T; Wuest F
    Nucl Med Biol; 2020; 90-91():74-83. PubMed ID: 33189947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PESIN multimerization improves receptor avidities and in vivo tumor targeting properties to GRPR-overexpressing tumors.
    Lindner S; Michler C; Wängler B; Bartenstein P; Fischer G; Schirrmacher R; Wängler C
    Bioconjug Chem; 2014 Mar; 25(3):489-500. PubMed ID: 24533789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging.
    Pan D; Xu YP; Yang RH; Wang L; Chen F; Luo S; Yang M; Yan Y
    Amino Acids; 2014 Jun; 46(6):1481-9. PubMed ID: 24633452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of macrocyclic chelators on the targeting properties of the 68Ga-labeled gastrin releasing peptide receptor antagonist PEG2-RM26.
    Varasteh Z; Mitran B; Rosenström U; Velikyan I; Rosestedt M; Lindeberg G; Sörensen J; Larhed M; Tolmachev V; Orlova A
    Nucl Med Biol; 2015 May; 42(5):446-454. PubMed ID: 25684649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of 18F-fluorodeoxyglucose PET/computed tomography parameters with tissue gastrin-releasing peptide receptor and integrin αvβ3 receptor levels in patients with breast cancer.
    Arslan E; Aksoy T; Can Trabulus FD; Kelten Talu C; Yeni B; Çermik TF
    Nucl Med Commun; 2020 Mar; 41(3):260-268. PubMed ID: 31895261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoenzymatic strategy for the synthesis of site-specifically labeled immunoconjugates for multimodal PET and optical imaging.
    Zeglis BM; Davis CB; Abdel-Atti D; Carlin SD; Chen A; Aggeler R; Agnew BJ; Lewis JS
    Bioconjug Chem; 2014 Dec; 25(12):2123-8. PubMed ID: 25418333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical comparison of Al18F- and 68Ga-labeled gastrin-releasing peptide receptor antagonists for PET imaging of prostate cancer.
    Chatalic KL; Franssen GM; van Weerden WM; McBride WJ; Laverman P; de Blois E; Hajjaj B; Brunel L; Goldenberg DM; Fehrentz JA; Martinez J; Boerman OC; de Jong M
    J Nucl Med; 2014 Dec; 55(12):2050-6. PubMed ID: 25413139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo evaluation of 64Cu-labeled SarAr-bombesin analogs in gastrin-releasing peptide receptor-expressing prostate cancer.
    Lears KA; Ferdani R; Liang K; Zheleznyak A; Andrews R; Sherman CD; Achilefu S; Anderson CJ; Rogers BE
    J Nucl Med; 2011 Mar; 52(3):470-7. PubMed ID: 21321264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A heterodimeric [RGD-Glu-[(64)Cu-NO2A]-6-Ahx-RM2] αvβ3/GRPr-targeting antagonist radiotracer for PET imaging of prostate tumors.
    Durkan K; Jiang Z; Rold TL; Sieckman GL; Hoffman TJ; Bandari RP; Szczodroski AF; Liu L; Miao Y; Reynolds TS; Smith CJ
    Nucl Med Biol; 2014 Feb; 41(2):133-9. PubMed ID: 24480266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of 64Cu/NOTA-[D-Tyr6,βAla11,Thi13,Nle14]BBN(6-14) monomer and dimers for prostate cancer PET imaging.
    Fournier P; Dumulon-Perreault V; Ait-Mohand S; Langlois R; Bénard F; Lecomte R; Guérin B
    EJNMMI Res; 2012 Feb; 2():8. PubMed ID: 22333272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (68)Ga-labeled NOTA-RGD-BBN peptide for dual integrin and GRPR-targeted tumor imaging.
    Liu Z; Niu G; Wang F; Chen X
    Eur J Nucl Med Mol Imaging; 2009 Sep; 36(9):1483-94. PubMed ID: 19360404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next Step toward Optimization of GRP Receptor Avidities: Determination of the Minimal Distance between BBN(7-14) Units in Peptide Homodimers.
    Fischer G; Lindner S; Litau S; Schirrmacher R; Wängler B; Wängler C
    Bioconjug Chem; 2015 Aug; 26(8):1479-83. PubMed ID: 26200324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural Investigations, Cellular Imaging, and Radiolabeling of Neutral, Polycationic, and Polyanionic Functional Metalloporphyrin Conjugates.
    Ciaffaglione V; Waghorn PA; Exner RM; Cortezon-Tamarit F; Godfrey SP; Sarpaki S; Quilter H; Dondi R; Ge H; Kociok-Kohn G; Botchway SW; Eggleston IM; Dilworth JR; Pascu SI
    Bioconjug Chem; 2021 Jul; 32(7):1374-1392. PubMed ID: 33525868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.